| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |